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Introduction
Acute respiratory distress syndrome (ARDS), the most severe 
form of acute lung injury (ALI), is a devastating clinical complica-
tion of bacterial sepsis, with a mortality rate of greater than 40% 
(1). ALI is characterized by an exaggerated host-defense immune 
response in which influx of inflammatory cells, such as neutrophils 
and macrophages, into the lung tissue perpetuates a vicious cycle 
of inflammation that amplifies the accumulation of these cells (2). 
A central pathogenic feature underlying ALI is the breakdown of 
lung endothelial barrier function due to widespread EC death and 
disassembly of endothelial adherens junctions (2–4).
The endothelium lines the entire vascular system, and the lung 
endothelium in particular comprises about 50% of all lung cells 
and receives the entire cardiac output. Lung ECs are thus invari-
ably exposed to circulating pathogens and bacterial endotoxins 
such as lipopolysaccharide (LPS), which are key for the pathogen-
esis of ALI (5). An intact endothelial barrier tightly controls lung 
vascular permeability (3) and leukocyte recruitment (6), whereas 
a disrupted endothelial barrier results in tissue edema, neutro-
phil influx, activation of procoagulant pathways, and release of 
proinflammatory cytokines such as IL-1β (2). Moderate increase 
in endothelial permeability during inflammation is an adaptive 
feature of the host defense response that helps resolve infection 
by enabling leukocyte transmigration, thus avoiding ALI, whereas 
severe infection can elicit an exaggerated inflammatory response 
and endothelial barrier breakdown that is ultimately responsible 
for the high mortality of septic ALI.
Endotoxin (LPS) liberated in large amounts in the circula-
tion after bacterial lysis initiates the septic cascade in Gram- 
negative bacterial infections (7). The canonical mammalian 
host-cell detection mechanism of LPS sensing occurs via the cell- 
surface TLR4 (8, 9). However, recent studies in macrophages have 
shown an additional intracellular LPS-sensing pathway that may 
be important for the pathogenesis of septic shock (10, 11). These 
studies showed that LPS breaching of the plasma membrane 
and binding of inflammatory caspases 4 and 5 in humans or the 
ortholog caspase-11 in mice activated macrophage pyroptosis, a 
form of programmed cell death resulting in rapid cell lysis (10–13). 
Caspase-11 cleavage of gasdermin D (Gsdmd) induces release of 
the active membrane pore-forming Gsdmd peptide, which leads to 
lytic death of cells by swelling (13–21). Studies of cytoplasmic LPS 
signaling have used LPS encapsulated by transfection reagents 
such as lipofectamine to mimic plasma membrane breaching by 
LPS in the setting of endotoxemia (10, 12, 22). Further, delivery of 
LPS packaged within bacterial microvesicles, which fuse with the 
plasma membrane without causing breach, resulted in intracellu-
lar LPS release and also activated inflammatory caspase signaling 
and pyroptosis (23, 24).
Pyroptosis is a programmed cell death mechanism that is dis-
tinct from apoptosis and necrosis; each type of programmed cell 
is regulated by distinct signaling mechanisms (25). Apoptosis, a 
nonlytic form of cell death, is initiated by caspases 2, 8, 9, and 10 
and requires the effector caspases 3, 6, and 7 (26). Necroptosis- 
like pyroptosis is a lytic cell death mechanism mediated by 
kinases such as RIPK3 (27). Although the molecular mechanisms 
of these types of programmed cell death differ, it is likely that 
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the complex process of inflammation involves multiple 
programmed cell death pathways, depending on the 
type and magnitude of the inciting stimulus and cell 
type. From an evolutionary perspective, pyroptosis of 
cells harboring intracellular bacteria or in which LPS has 
breached the plasma membrane is an effective means 
of eliminating an intracellular bacterial niche and acti-
vating the host through release of inflammatory media-
tors such as IL-1β, while sparing uninfected neighboring 
cells (13, 28–30). Thus, pyroptosis induced by inflam-
matory caspases 1/4/5/11 is an innate immune response 
distinct from the canonical inflammasome activation 
pathway via cell-surface TLR4 (11, 31–34). However, 
caspase-11 can also be immunopathologic in sepsis (35). 
Caspase-11–deficient mice were protected in endotox-
emic shock (10, 11), suggesting that in the setting of an 
overwhelming inflammatory response, the potentially 
protective pyroptotic mechanism activates an exagger-
ated pathologic response due to overwhelming cell lysis.
The role of the inflammatory caspases 4/5/11 in 
mediating cytoplasmic LPS signaling and pyroptosis has 
until now been primarily studied in macrophages or den-
dritic cells (11, 12, 14, 28, 32, 36). Their role in destroying 
the endothelial barrier through widespread endothelial 
death and pathogenesis of ALI remains unknown. Here, 
we tested the hypothesis that lung ECs are a primary tar-
get for pyroptosis via intracellular sensing of LPS by the 
inflammatory caspases 4/5/11 and that endothelial pyro-
ptosis is required for the induction of ALI.
Results
LPS in ECs induces pyroptotic cell death via activation of 
inflammatory caspases. We first addressed the question 
of whether ECs sense LPS in the cytoplasm and ini-
tiate caspase-4/5/11–mediated pyroptosis. To mimic 
LPS internalization by uptake of bacterial microve-
sicles (23), we encapsulated FITC-labeled LPS in 
lipofectamine-based liposomes (15, 17) and transfected 
ECs. We observed the intracellular uptake of FITC-LPS 
by imaging flow cytometery (37) (Figure 1, A and B). This 
increased in a time-dependent manner so that half the 
endothelium displayed internalized LPS by 6 hours (Figure 
1C). To assess in vivo uptake of LPS, FITC-LPS was injected 
i.p. in C57BL/6 mice. Here, we also observed the uptake of 
LPS in lung microvascular ECs (Supplemental Figure 1; sup-
plemental material available online with this article; https://
doi.org/10.1172/JCI94495DS1). Using confocal micros-
copy, we generated a 3D Z stack image, which confirmed 
intracellular localization of systemically injected FITC-LPS 
in the lung endothelium (Supplemental Video 1). We next 
addressed whether intracellular LPS in ECs induced pyro-
ptosis. LPS transfection caused massive EC lysis, whereas 
extracellular incubation with the same dose of LPS had no 
significant effect (Figure 1D). LPS transfection induced 
marked lactate dehydrogenase (LDH) release (~40%), 
which was far greater than the cell lysis achieved by apop-
tosis (Figure 1E).
Figure 1. Intracellular LPS induces EC pyroptosis via activation of inflammatory 
caspases in mice and humans. (A) Flow cytometry histograms and (B) representative 
cytometry images of hMVECs transfected with 2 μg/ml FITC-labeled LPS (O111:B4) for 
3 hours. LPS fluorescence in green and nuclear staining in red show that LPS crossed 
the EC plasma membrane. Scale bar: 20 μm. BF, bright field. (C) Time course of hMVEC 
intracellular FITC-LPS fluorescence in the presence of a transfection (T) reagent. Results 
are shown as mean ± SEM. n = 5. **P < 0.01 from baseline; ^P < 0.01 from previous 
group using ANOVA. (D) Phase-contrast micrographs of control hMVECs after a 16-hour 
period of LPS (2 μg/ml) incubation and after a 16-hour period of LPS transfection (2 μg/
ml) show that LPS transfection, but not LPS incubation, induced lytic cell death. Scale 
bars: 100 μm. (E) Release of LDH showed that LPS incubation (2 μg/ml) for 16 hours 
or staurosporine-induced (STP-induced) apoptosis resulted in minimal LDH release, 
whereas LPS transfection (2 μg/ml) led to marked cell lysis. Cells were primed with 
an initial exposure to LPS (500 ng/ml for 3 hours). Cell lysis was blocked by the pan-
caspase inhibitor Z-VAD-FMK or knockdown (KD) of the human inflammatory caspases 
4 and 5 (Casp4/5). Results are shown as mean ± SEM. n = 5. ***P < 0.001 using ANOVA.
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the role of a priming signal in ECs through stimulation with 
TLR agonists in activating pyroptosis. LPS priming via TLR4 
induced expression of caspase-11 in murine ECs (Figure 2A). 
Human caspase-4 is thought to be constitutively expressed 
in phagocytic cells (38), whereas human caspase-5 is induc-
ible (39). We observed basal expression of caspase-4 and 
caspase-5 in human ECs, and both caspases were markedly 
upregulated in human ECs by priming with extracellular LPS 
(Figure 2B); the priming effect was more prominent with 
caspase-4 (Figure 2C). Primed ECs showed lysis as early as 3 
hours after LPS transfection, whereas significant pyroptosis 
was observed in nonprimed cells only after 12 hours (Figure 2D), 
consistent with increased sensitivity of ECs due to priming- 
Cell lysis was blocked by the pan-caspase inhibitor z-VAD-FMK 
(Figure 1E), confirming that this was due to a caspase- 
mediated lytic cell death. To identify the underlying mechanism, 
we investigated the role of the inflammatory caspases 4 and 5 in 
human ECs. Depletion of caspase-4 or -5 by siRNAs prevented 
LPS-induced pyroptosis (Figure 1E). Further, LPS internaliza-
tion triggered the pyroptosis response in all ECs studied, includ-
ing human dermal microvascular endothelial cell line HMEC 1, 
human umbilical vein ECs (HUVECs), and mouse lung microvas-
cular ECs (mMVECs-L) (Supplemental Figure 2A and Supplemen-
tal Figure 3, A and B).
TLR4-mediated LPS signaling synergizes with intracellu-
lar LPS to activate endothelial pyroptosis. We next addressed 
Figure 2. TLR4-mediated LPS signaling is required 
for activation of endothelial pyroptosis. Immunoblot 
analysis of the inflammatory caspase-11 in mMVECs (A) 
and the inflammatory caspases 4 and 5 in hMVECs (B) 
in the presence or absence of priming with extracellular 
500 ng/ml LPS for 3 hours prior to transfecting the cells 
with 2 μg/ml LPS for 16 hours. (C) Quantification of 
the inflammatory caspase expression shows signifi-
cant upregulation of caspases 4 and 5 in human ECs 
and caspase-11 in mouse ECs with priming. Statistics 
obtained from Student’s 2-tailed t test. (D) hMVECs 
were first primed with extracellular (E) LPS or PBS, then 
transfected (T) with LPS or only incubated (I) with extra-
cellular LPS. (E) Dose dependence of EC lysis in hMVECs 
induced by intracellular LPS. (F) LDH release by mMVEC 
isolated from WT, Tlr4–/–, and Casp11–/– mice after 
internalization of LPS for 16 hours. CTRL, control. (G) 
Western blot and (H) ELISA detection of mature IL-1β in 
hMVEC lysates and culture supernatants 16 hours after 
endothelial transfection with LPS (2 μg/ml) or without 
LPS transfection. (H) There was a significant amount of 
mature IL-1β release when ECs were primed with extra-
cellular LPS and subsequently exposed to intracellular 
LPS for 16 hours. Results are shown as mean ± SEM. 
n ≥ = 5. *P < 0.05; ***P < 0.001. All statistics except C 
obtained from ANOVA.
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LPS in the absence of priming, but there was marked mature 
IL-1β release when ECs were primed with extracellular LPS and 
subsequently exposed to cytoplasmic LPS (Figure 2H). Thus, 
priming of ECs through upregulation of caspases 4/5/11 mark-
edly enhanced IL-1β production, maturation, and secretion and 
the full activation of pyroptosis.
Caspase-11 is required for endotoxemia-induced lung vascular 
hyperpermeability and mortality. To evaluate the role of caspase-11 
in the pathogenesis of ALI-induced endotoxemia, we first deter-
mined lung microvessel filtration coefficient (as a measure of lung 
vascular permeability) in WT and Casp11–/– mice. At 6 hours after 
exposure to a lethal dose of systemic LPS (40 mg/kg i.p.), WT 
mice showed a marked increase in lung vascular leakiness that is 
characteristic of ALI, while the response was abrogated in Casp11–/– 
mice (Figure 3A). Cross sections of lung showed edema in WT 
mouse lungs, whereas Casp11–/– mice were protected (Figure 3B). 
Analysis for leukocyte accumulation (Figure 3C) and myeloperox-
idase (MPO) activity (Figure 3D) (used as a marker for neutrophil 
influx) demonstrated that caspase-11 was required for leukocyte 
infiltration in endotoxemia-induced ALI.
induced upregulation of inflammatory caspases. We also 
observed that LPS concentrations in primed ECs as low as 50 
ng/ml induced pyroptosis (Figure 2E). To determine whether 
alternate priming pathways could substitute for TLR4, we also 
primed cells with TLR2 ligand Pam3CSK4 and TLR3 ligand 
poly(I:C). Here we found that priming with these TLR ligands 
also induced cell lysis similar to LPS (Supplemental Figure 2 and 
Supplemental Figure 3). As TLR4 may be dispensable for intra-
cellular LPS-mediated pyroptosis in macrophages (10, 11), we 
isolated ECs from Tlr4–/– mice and primed these cells with either 
Pam3CSK4 or poly(I:C) instead of LPS. These cells also responded 
to cytoplasmic LPS similarly to WT ECs (Figure 2F), whereas 
ECs generated from Casp11–/– mice demonstrated no evidence 
of pyroptosis. Thus, caspase-11, but not TLR4, is required for 
intracellular LPS-mediated endothelial pyroptosis.
Caspases 4/5/11 activate NLRP3 inflammasome, resulting 
in IL-1β cleavage (31). We observed increased expression of 
pro–IL-1β after priming, while maturation required cytoplasmic 
LPS in ECs (Figure 2G). There was minimal release of mature 
IL-1β with extracellular LPS incubation or with intracellular 
Figure 3. Requirement for caspase-11 
expressed in nonhematopoietic cells in 
mediating endotoxemia-induced acute 
lung vascular injury and mortality. (A) 
Lung microvessel filtration coefficient (a 
measure of lung vascular permeability) 
was determined in WT and Casp11–/– mice, 
and the data points depicting individual 
mice are shown. Mice were exposed to 
systemic LPS (40 mg/kg i.p.) for 6 hours. 
Statistics obtained from 2-tailed Student’s 
t test.(B) H&E-stained cross section of the 
lung from control mice and LPS-exposed 
mice at 6 hours shows interstitial edema 
(indicated by arrows) in WT but not in 
Casp11–/– mice. Scale bars: 100 μm. V, lung 
microvasculature. Images are represen-
tative of 5 animals. Quantitative analysis 
for leukocyte infiltration in lungs (C) and 
lung tissue MPO activity (D). *P < 0.05; 
**P < 0.01; ***P < 0.001. Statistics in C 
and D obtained from ANOVA. (E) Survival 
of Casp1/11DKO mice and Casp1–/– Casp11Tg 
mice subjected to a lethal dose of LPS (40 
mg/kg i.p.) was assessed and is presented 
as a Kaplan-Meier plot. (F) Casp11–/– mice 
underwent BM irradiation and transplanta-
tion with WT BM to reconstitute caspase-11 
in hematopoietic cells. Global Casp11–/– mice 
as well as Casp11–/–mice transplanted with 
WT hematopoietic-lineage cell (BMT) chi-
meras were protected from lethal sepsis, 
while nontransplanted WT control mice 
were not.
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from lethal sepsis, while control WT mice were not (Figure 3F), 
thus demonstrating the crucial role of caspase-11 expressed in 
nonhematopoietic cells for endotoxemic mortality.
We also investigated whether caspase-11 is important in the 
mechanism of ALI and mortality induced by polymicrobial sepsis 
in the cecal ligation puncture (CLP) model. Lung sections from 
Casp11–/– mice showed reductions in inflammation and lung injury 
compared with those from control mice after CLP for 12 hours 
(Supplemental Figure 4A). Deletion of caspase-11 prevented 
CLP-induced mortality (Supplemental Figure 4B).
Endothelial-expressed caspase-11 is required for endotoxin-induced 
ALI. We next investigated whether ALI induced by endotox-
in was due to caspase-11 expressed in the endothelium per se. 
Here, we used mice carrying a LoxP site–flanked Casp11 for tis-
To differentiate between the roles of inflammatory caspase-1 
and caspase-11 in inducing mortality, survival of Casp1–/– Casp1–/– 
(Casp1/11DKO) mice and Casp1–/– Casp11Tg mice was studied following 
exposure to a lethal dose of LPS (40 mg/kg i.p.). Genetic deletion of 
both inflammatory caspases resulted in 90% survival, whereas mice 
lacking caspase-1 but expressing caspase-11 exhibited 0% survival 
within 72 hours (Figure 3E), indicating the central role of caspase-11 
in the mechanism of endotoxemia-induced death.
We also determined whether the protective effect of caspase-11 
deletion was due to caspase-11 expressed in hematopoietic versus 
nonhematopoietic cells. Casp11–/– mice underwent BM irradiation 
and transplantation with WT BM to reconstitute WT caspase-11 in 
hematopoietic cells. Global Casp11–/– mice as well as Casp11–/– mice 
transplanted with WT hematopoietic-lineage cells were protected 
Figure 4. EC-expressed caspase-11 Is 
required for ALI induced by endotox-
emia. (A) Lung microvessel filtration 
coefficient was assessed in Casp11fl/fl  
and Casp11EC–/– mice following expo-
sure to systemic LPS (40 mg/kg i.p.) 
for 6 hours. (B) Representative H&E 
staining (n = 6 mice per group) of lung 
sections from Casp11fl/fl and Cas11EC–/– 
mice shows marked reduction in 
inflammation and lung injury in the 
latter group at 6 hours following LPS 
(40 mg/kg i.p.). Scale bars: 100 μm. 
(C) A similar protective effect was 
also observed when assessing the 
lung wet/dry ratio. (D) Quantitative 
analysis for neutrophil infiltration in 
the lungs by assessing lung tissue 
MPO activity. (E) Circulating levels of 
the proinflammatory cytokine IL-1β, 
which is released during pyroptosis. 
Scatter plots show mean ± SEM. 
Dots represent data from individual 
mice. ***P < 0.001. (F) Kaplan-Meier 
survival plots of mice challenged 
with a lethal LPS dose (40 mg/kg 
i.p.) show that EC-specific deletion 
of caspase-11 improves survival from 
0% to 50%–60%. Statistics obtained 
from 2-tailed Student’s t test.
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Figure 5. Pyroptotic ECs generate MP in 
caspase-11–dependent manner. (A and B) Flow 
cytometry showing size calibration and gate 
definition of MPs using fluorescent polystyrene 
bead standards of various sizes. MPs were gated 
by size gating (<2 μm) correlated with object area 
in the bright field channel and intensity of the dark 
field side scatter (SSC). (C) Pyroptotic ECs released 
CD31+ MPs. Supernatants were collected from either 
control hMVECs only incubated (I) with LPS or 
primed cells transfected with LPS (2 μg/ml) for 16 
hours. Samples were then analyzed using imaging 
flow cytometer. (D) Representative images of MPs 
from control (gray), LPS incubation (magenta), 
and LPS transduction (T) (blue). (E) Pyroptotic ECs 
displayed increase in total MP counts as well as 
enhanced CD31+ expression on MPs. Representative 
flow cytometry dot blots (F) and quantification (G) 
of MPs measured in the plasma of WT, Casp11–/–, 
Casp11fl/fl, and Casp11EC–/–mice 6 hours after LPS 
challenge (40 mg/kg i.p.). Endothelial-specific 
deletion of caspase-11 prevented the generation 
of endothelial MPs similarly to global caspase-11 
deletion, thus demonstrating that EC MP release 
was due to the activation of endothelial caspase-11. 
(H) Micrograph of MPs from mouse plasma, visu-
alized by imaging flow cytometry, showing MPs of 
endothelial (CD31+CD41–) and platelet (CD31+CD41+) 
origins. Assessment of endothelial-derived MPs 
from plasma of healthy volunteers (control) and 
ARDS patients (described in Supplemental Table 
1) in a representative flow cytometry dot plot (I) 
and a bar graph quantification (J) shows significant 
increases in endothelial MP release, consistent with 
endothelial pyroptosis during ALI/ARDS in patients.  
** P < 0.01; *** P < 0.001 by ANOVA (E and G) and 
2-tailed Student’s t test (J).
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sue-specific deletion of caspase-11 and induced endothelial- 
specific deletion of caspase-11 (Casp11EC–/–) by crossing Casp11fl/fl 
mice with Endo-SCL-Cre mice (40), which express the Cre- 
recombinase in the adult endothelium upon induction with 
tamoxifen. Lung microvessel filtration coefficients determined 
in Casp11EC–/– mice following exposure to systemic LPS (40 mg/
kg i.p.) demonstrated that EC-specific deletion of caspase-11 did 
not affect baseline lung vascular leakiness, but fully prevented 
LPS-induced lung vascular leakiness in contrast with Casp11fl/fl 
mice (Figure 4A). Lung sections from Casp11EC–/– mice showed 
marked reduction in inflammation and lung injury at 6 hours 
following LPS (40 mg/kg i.p.) as compared with sections from 
Casp11fl/fl mice (Figure 4B). Endothelial-specific caspase-11 dele-
tion also prevented the increase in lung wet/dry weight ratio, a 
measure of tissue edema (Figure 4C). Further, analysis for neu-
trophil infiltration (Figure 4D) and circulating levels of IL-1β, 
released during pyroptosis, also showed marked reductions fol-
lowing EC-specific caspase-11 deletion, which was comparable 
to protection seen in mice with global caspase-11 deletion (Figure 
4E). Kaplan-Meier survival plots of mice challenged with a lethal 
LPS dose (40 mg/kg i.p.) demonstrated that EC-specific deletion 
of caspase-11 improved survival from 0% to 50%–60%, whereas 
global caspase-11 deletion increased survival to 70%–80% at 
7 days (Figure 4F). Similar results were seen in lung microves-
sel filtration coefficient (Supplemental Figure 5A) and Kaplan- 
Meier survival analysis (Supplemental Figure 5B) of Casp11EC–/– 
mice challenged with CLP for 12 hours, thus demonstrating the 
central role of endothelial caspase-11 in mediating ALI and mor-
tality in polymicrobial sepsis.
Pyroptotic ECs generate microparticles in a caspase-11–dependent 
manner. It remains unclear whether EC-derived microparticles 
(MPs) are generated during caspase-11–dependent pyroptosis in 
incipient ALI. Here, we used imaging flow cytometry to evalu-
ate MP generation from pyroptotic ECs. MPs were identified by 
size gating (<2 μm) correlated with object area in the bright field 
channel and intensity of the dark field side scatter (Figure 5, A 
and B). We observed that ECs released MPs in vitro following LPS 
transfection, but not LPS incubation (Figure 5C), indicating that 
cytoplasmic LPS entry was required for MP release. Pyroptotic 
ECs displayed increases in total MP counts, and percentages of 
MPs positive for the endothelial surface marker PECAM (CD31+) 
increased to 90% (Figure 5, D and E), indicating that fragmented 
endothelial plasma membrane was the primary source of MPs 
released by cytoplasmic LPS challenge.
We next examined MP generation in vivo during endotoxemia. 
EC MPs were assessed by labeling for CD31, while the platelet 
marker CD41 was used to exclude platelet MPs, which are also pos-
itive for CD31. Representative flow cytometry dot blots (Figure 5F) 
and quantification (Figure 5G) of circulating MPs in WT, Casp11–/–, 
Casp11fl/fl, and Casp11EC–/– mice 6 hours after LPS challenge (40 mg/
kg i.p.) demonstrated that endothelial-specific deletion of caspase-11 
prevented the generation of endothelial MPs. This response was 
similar to that observed with global caspase-11 deletion, indicating 
that EC MP release was due to activation of endothelial caspase-11. 
Micrographs of MPs in mouse plasma showed that the majority of 
circulating MPs in endotoxemia were derived from ECs (Figure 
5H). To address relevance to ARDS, we determined endothelial 
MP levels in the plasma of healthy volunteers and ARDS patients 
(described in Supplemental Table 1). Flow cytometry dot plot (Fig-
ure 5I) and quantification (Figure 5J) showed significantly greater 
release of endothelial MPs in ALI/ARDS patients, consistent with 
the results in mice above. To assess whether the increase in the 
circulating endothelial MP count was also seen in other forms of 
pulmonary edema, we quantified endothelial MPs in patients with 
cardiogenic pulmonary edema (CPE). No significant difference was 
observed in the circulating MP levels of CPE patients when com-
pared with control subjects(Supplemental Figure 6), demonstrating 
the relevance of the circulating endothelial MP count as an indica-
tor of widespread endothelial destruction during endotoxemia.
Endothelial caspase-11 activation is required for mature IL-1β 
generation and Gsdmd cleavage. IL-1β is a proinflammatory cyto-
kine synthesized as a 31-kDa precursor protein and proteolytically 
activated by inflammatory caspases to release mature IL-1β (also 
known as p17) protein during pyroptotic cell death (12–14, 18, 21). 
To address whether IL-1β cleavage is mediated by EC-specific 
caspase-11, Casp11fl/fl and Casp11EC–/– mice were challenged with 
LPS (40 mg/kg i.p.). Lung ECs were isolated and immunoblot-
ting was performed for pro–IL-1β and mature IL-1β protein. EC- 
specific deletion of caspase-11 prevented pro–IL-1β generation fol-
lowing endotoxemia (Figure 6, A and B). Another critical target of 
caspase-11 is the pore-forming pyroptosis perforin Gsdmd, which 
is cleaved into its active form by caspase-11 and forms pores pro-
moting cell swelling and lytic cell death (12, 14–17). We observed 
that cytoplasmic LPS in human ECs markedly increased forma-
tion of the active, cleaved Gsdmd p30 protein (Figures 6, C and D). 
Moreover Gsdmd cleavage was inhibited in lung ECs of Casp11EC–/– 
mice following LPS challenge (Figure 6, E and F).
Discussion
Pyroptosis of phagocytes mediated by inflammatory caspases 
plays an important role in innate immune defense against intra-
cellular bacteria and endotoxin (13, 28–30, 41). It is characterized 
by lytic cell death induced by the binding of intracellular LPS to 
caspases 4/5 in human cells and caspase-11 in mouse cells, which 
in turn leads to Gsdmd-induced pore formation and cleavage 
of inflammatory procytokine IL-1β, unlike other forms of pro-
grammed cell death (25). Thus, pyroptosis strikes a precarious 
balance between activating the host-defense response and mini-
mizing collateral tissue damage (10, 21). As unfettered pyroptosis 
can induce tissue injury, targeting caspase-activated pyroptosis in 
specific cell types may be a useful strategy for limiting inflamma-
tory tissue damage and organ failure without compromising host 
defense. The present study investigated the role of pyroptosis spe-
cifically in ECs and the potential of targeting endothelial pyropto-
sis in ALI. ECs demonstrated lytic cell death, activation of Gsdmd, 
and release of the proinflammatory cytokine IL-1β, processes that 
are dependent on caspase-4/5 in human ECs and caspase-11 in 
mouse ECs. We demonstrated on the basis of genetic caspase-11 
deletion studies in mice the requisite role of endothelial pyroptosis 
in the mechanism of LPS-induced ALI. We showed that LPS sens-
ing in ECs via caspase-11 in mice mediated pyroptosis and hence 
was required for the development of ALI. LPS entered endothe-
lial cytoplasm via bacterial microvesicles or bacterial breaching 
of the endothelial plasma membrane, and intracellular LPS then 
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ALI, establishing the central role of caspase-11 expressed in ECs 
in the mechanism of ALI.
Priming with inflammatory activators, such as LPS, poly(I:C), 
IFN-β, and IFN-γ, increases the expression of inflammasome 
components, which in turn are required for activation of the non-
canonical inflammasome pathway responsible for pyroptosis 
induction in phagocytic cells (10, 11). Priming with extracellular 
LPS occurred via LPS binding to TLR4 and downstream TLR4 sig-
naling, whereas pyroptosis induction was mediated via a TLR4- 
independent mechanism, since intracellular LPS induced pyro-
ptosis by directly binding to the intracellular caspases. We demon-
strated that priming by extracellular LPS enhanced the expres-
sion of caspase-4 and caspase-5 in human ECs and caspase-11 
in mouse ECs, thereby augmenting the subsequent pyroptotic 
response induced by intracellular LPS binding to these inflam-
matory caspases. Although ECs in the absence of priming can 
also undergo pyroptosis, this requires prolonged exposure to LPS. 
Thus, the threshold for LPS-induced pyroptosis in the endothelium 
set by expression of inflammatory caspases may serve to prevent 
undue activation of the potentially harmful pyroptotic pathway in 
settings of mild or transient endotoxemia.
induced caspase-4/5/11 activation, which triggered pyroptosis via 
Gsdmd cleavage (Figure 7). We demonstrated that widespread 
lysis of ECs resulted in severe disruption of the endothelial barri-
er, release of proinflammatory cytokines, influx of leukocytes, and 
lung edemagenesis, all hallmarks of ALI (2, 42, 43).
Caspase-11–dependent pyroptosis triggered by intracellular 
LPS was described in macrophages and dendritic cells (10–12, 
14, 16, 22, 30, 36); however, the critical role of this noncanon-
ical intracellular LPS sensing mechanism in ECs has not been 
established. Here, we demonstrated a highly sensitive and intri-
cate intracellular LPS-sensing machinery in ECs, which result-
ed in caspase-4/5/11–dependent endothelial lysis. Distinctive 
features included rupture of the plasma membrane and release 
of LDH, and maturation and release of IL-1β as well as cleavage 
of Gsdmd, the pyroptosis effector perforin (12, 14, 15, 17). We 
demonstrated that endothelial-specific deletion of caspase-11 
in 2 distinct models of ALI, endotoxemia and the CLP model of 
polymicrobial sepsis, prevented LPS-induced increases in lung 
vascular endothelial permeability and markedly enhanced sur-
vival. BM transplantation of WT hematopoietic cells in mice with 
global caspase-11 deficiency abrogated endotoxemia-induced 
Figure 6. Endothelial caspase-11 activation 
is required for generation of mature IL-1β 
and Gsdmd. (A and B) Casp11fl/fl and Casp11EC–/– 
mice (n = 3) were challenged with LPS (40 
mg/kg i.p.) for 6 hours. ECs were isolated 
from lungs, and immunoblot analysis was 
performed for pro–IL-1β, mature IL-1β, and 
caspase-1 cleavage, as shown in representa-
tive immunoblots and the bar graph quantifi-
cation. (C and D) Immunoblot analysis of the 
pore-forming mediator of pyroptosis Gsdmd 
showed that LPS (2 μg/ml) transfection mark-
edly increased the formation of the active, 
cleaved Gsdmd p30 protein in human ECs. (E 
and F) Gsdmd cleavage was suppressed in ECs 
of Casp11–/– mice (n = 3) following LPS chal-
lenge for 6 hours. ***P < 0.001 versus control 
or as indicated. Data are shown as mean ± 
SEM. Statistics obtained from ANOVA.
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plasma membrane in sepsis are required for activation of endo-
thelial pyroptosis; they thereby contribute to the development of 
fulminant pulmonary edema and ALI. Thus, therapeutic strate-
gies aimed at preventing endothelial pyroptosis may preserve lung 
endothelial integrity and be beneficial in treating ALI/ARDS.
Methods
Mice. Mice were bred and maintained under specific pathogen–free 
conditions at the University of Illinois at Chicago animal facility. All 
mice were randomly assigned to experimental animal groups. Casp11–/–, 
Casp1/11DKO, Casp1–/– (Casp1–/–Casp11Tg), and Casp11fl/fl mice were provid-
ed by Vishva Dixit (Genentech) (12). EC-specific caspase-11–knockout 
mice were generated by backcrossing Casp11fl/fl mice with Endo-SCL-
Cre mice, which express an endothelial-specific Cre in the adult (40). 
C57BL/6J mice initially acquired from The Jackson Laboratory and bred 
at the University of Illinois at Chicago were used as WT controls. Male 
or female mice 8 to 12 weeks old were used for all experiments.
Materials. Human lung microvascular ECs (hMVECs), endothelial 
growth medium 2 (EBM-2), and a nucleofector kit and electroporation 
system were obtained from Lonza. FuGENE transfection reagent was 
procured from Promega. Anti–Alexa Fluor 568 and 488 antibodies and 
ProLong Gold Antifade were obtained from Invitrogen. Mouse anti– 
rabbit IgG (conformation specific) antibodies were purchased from Cell 
Signaling Technology. Ultra-pure LPS (E. coli O111:B4), Pam3CSK4, 
and poly(I:C) LMW were obtained from InvivoGen. We obtained 
antibodies targeting caspase-1 (AdipoGen, AG-20B-0042-C100), 
IL-1β (R&D Systems, AF-401-NA), caspase-11 (Novus Biologicals, 
NB-120-10454), caspase-4 (Santa Cruz Biotechnology Inc., sc-56056), 
caspase-5 (Santa Cruz Biotechnology Inc., sc-393346), β-actin (Santa 
Cruz Biotechnology Inc., sc-47778), GAPDH (Abcam, ab-8245), 
Intracellular LPS sensing in ECs also highlights its role as 
an immune cell and regulator of innate immunity. ECs line the 
entire vasculature and are thus the first point of contact for circu-
lating bacterial toxins and pathogens. A responsive endothelial- 
based LPS detection system thus provides a defense mecha-
nism to activate host defense at the blood-tissue interface. In a 
2-tiered hierarchy of immune surveillance proposed by Iwasaki 
and Medzhitov (44), the EC should be included not only as an 
“effector cell” regulating influx of inflammatory cells and fluid 
and plasma proteins into tissue, but also as a cell capable of sens-
ing intracellular LPS and activating pyroptosis.
An important translational finding was that ECs undergoing 
pyroptosis released MPs. MPs derived from ECs were reported to 
be elevated in sepsis (45) as well as other forms of vascular injury 
(46–48), but their link to endothelial pyroptosis is not known. Our 
findings show that endothelial MPs were increased in endotox-
emic WT mice but not in Casp11–/– mice. In addition, we observed 
increased endothelial MPs in plasma from ARDS patients when 
compared with healthy subjects, suggesting that circulating MP 
levels could be a biomarker for endothelial pyroptosis in ALI/
ARDS patients and help stratify patients who may benefit from 
therapeutic interventions to contain endothelial pyroptosis. Con-
ventional flow cytometry represents the mainstay of MP measure-
ments, yet application toward characterization of submicrome-
ter MPs remains a challenge due to low sensitivity and accuracy. 
Imaging flow cytometry allowed us to interrogate each event that 
passes through the flow cell, pinpointing the fluorescent signals 
and allowing for the detection of MP populations (49). Our studies 
suggest that endothelial MPs serve as a biomarker for caspase-11–
mediated endothelial pyroptosis, but they also raise the intriguing 
question of whether MPs themselves can initiate signaling events 
that perpetuate or amplify endothelial injury and pyroptosis.
Gsdmd has been identified through genetic screening as a 
key mediator of pore formation of cells undergoing pyroptosis 
(12, 14–18). Gsdmd is a critical target of caspase-11 (19), which 
cleaves it to generate N-terminal (NT) fragments, which are 
the “executioners” of pyroptosis (12, 14). Overexpression of 
cleaved Gsdmd-NT alone induced pyroptosis independently of 
caspase-11 in vitro (14). Also, BM-derived macrophages (BMDMs) 
lacking functional Gsdmd were resistant to death in response to 
intracellular LPS, whereas deletion of inflammasome compo-
nents or caspase-1 continued to exhibit Gsdmd cleavage (12, 14). 
However, the interrelationship of caspase-1 and caspase-11 and 
the mechanisms involved in endothelial pyroptosis and related 
ALI remain unclear. Endothelial-specific caspase-11 depletion 
prevented LPS-induced caspase-1 cleavage, but had no effect on 
the basal caspase-1 expression. Thus, studies are needed to clar-
ify overlapping roles of caspase-1 and caspase-11 in endothelial 
pyroptosis. Even though our studies establish an essential role 
for endothelial caspase-11 in mediating pyroptosis of the endo-
thelium and ALI, it remains unknown whether this process also 
activates the endothelial inflammasome in a noncanonical man-
ner similar to that reported for phagocytic cells (12, 14).
In summary, we demonstrate that pyroptosis of ECs has a fun-
damental homeostatic role in host defense and immune surveil-
lance functions of the microvasculature. Increased expression of 
caspase-4/5 in human ECs and LPS breaching of the endothelial 
Figure 7. Model of EC caspase-11–dependent mechanism of endothelial 
pyroptosis and ALI. LPS enters the endothelial cytoplasma via bacteri-
al microvesicles or by bacterial breaching of the EC plasma membrane. 
Intracellular LPS then triggers caspase-11–dependent EC pyroptosis and 
disrupts the endothelial barrier, resulting in pulmonary edema, release of 
proinflammatory cytokines, fluid protein leakage, and massive influx of 
leukocytes. PMN, polymorphonuclear leukocytes.
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Evans blue–albumin was injected into anesthetized mice and allowed 
to circulate in the blood vessels for 30 minutes. Intravascular Evans 
blue was washed by PBS perfusion from the right ventricle for 2 min-
utes. Mouse lungs were excised, weighed, homogenized in 1 ml PBS, 
and extracted overnight in 2 ml formamide at 60°C. Evans blue con-
centration in lung homogenate supernatants was quantified by the 
spectrophotometric method at absorbance of 620 and 740 nm. Left 
lungs from the same mice used for Evans blue–albumin extravasation 
were excised and completely dried in the oven at 60°C overnight for 
calculation of lung wet/dry ratio.
Cytokine and chemokine measurements. Blood plasma and tissue 
homogenate from Casp11+/+ and Casp11–/– mice injected with LPS (40 
mg/kg) or saline were analyzed for the presence of IL-1β, IL-6, TNF-α, 
and MIP-1α, using a commercially available ELISA kit (R&D Systems).
BM transplantation studies. Recipient mice were lethally irradiated 
with 10 Gy at a dose rate of 2 Gy/min. Before irradiation, the recipient 
mice were maintained on acidified, antibiotic water for 2 to 3 days. At 
24 hours after irradiation, the mice were given a retroorbital intrave-
nous injection of 3 million donor BM cells. BM cells were obtained by 
flushing tibia and femur cavities using cold RPMI 1640 containing 2% 
FBS and 100 IU/ml penicillin and streptomycin. The cells were passed 
through a sterile 40-μm nylon cell strainer, washed twice with serum-
free RPMI 1640, and resuspended in HBSS (with Ca2+ and Mg2+) for 
injection. All subsequent experiments to assess endotoxemic re-
sponses were performed 6 to 8 weeks after BM transplantation.
LDH assay. hMVECs were cultured overnight in 96-well plates 
before being primed for 5 to 6 hours with 1 μg/ml LPS, Pam3CSK4, 
or 5 μg/ml poly(I:C) in Opti-MEM (Life Technologies). Primed cells 
were transfected with 2 μg/ml LPS using Lipofectamine 2000 reagent 
(Invitrogen) for 16 hours. ELISAs were used to measure IL-1β (R&D 
Systems) in culture supernatants. A CytoTox 96 Non-Radioactive 
Cytotoxicity Assay (Promega) measured cell death according to the 
manufacturer’s instructions.
Lung injury studies. For in vivo experiments, we used EC-specific 
caspase-11–deficient mice generated by tamoxifen (2 mg/d for 5 days) 
administered i.p. into Endo-SCL-Cre Casp11fl/fl mice (C57BL/6 back-
ground), in which tamoxifen induced expression of a fusion protein of 
Cre recombinase with the modified estrogen receptor binding domain 
(Cre ERT2) under the control of the Scl promoter.
Mice received a single dose (40 mg/kg) of LPS (E. coli 0111:B4, 
InvivoGen) administered i.p. For histology, paraffin-embedded tissue 
sections were stained with H&E or Leder stain.
Caspase-4/5 knockdown. hMVECs were nucleofected with 
300 nM siRNA according to the manufacturer’s instructions (Amaxa 
Nucleofector Technology). The following validated siRNAs were 
used: CASP4, ON-TARGETplus SMART POOL Human CASP4 
SiRNA (L-004404-00-0005, Dharmacon), CASP5, ON-TARGET-
plus SMART POOL Human CASP5 SiRNA (L-004405-02-0005, 
Dharmacon), and a nontargeting pool (Dharmacon).
MP analysis. Imaging cytometry was performed with the Flow-
Sight Instrument (Amnis Corp.). Size calibration beads were pur-
chased from Molecular Probes. All antibodies were purchased from 
BD Biosciences, unless otherwise stated, including anti-human 
CD31 AF647, anti-human CD41 FITC, anti-mouse CD31 APC, and 
anti-mouse CD41 FITC. Calibration beads were diluted in double– 
sterile-filtered (0.22 μm) PBS after vortexing to disperse. Cytometry 
analysis was performed immediately after staining.
VE-cadherin (Santa Cruz Biotechnology Inc., sc-6458), and Gsdmd 
(Santa Cruz Biotechnology Inc., sc-393656). Anti-human CD31-APC 
and CD41-FITC antibodies were purchased from BD Bioscience.
EC culture. mLMVECs-L were isolated as previously described. In 
brief, blood-free mouse lungs were minced, digested with collagenase 
at 37°C for 45 minutes, triturated, and centrifuged at 1,000 g. Cell sus-
pension was incubated with PECAM-1–coated Dynabeads for 1 hour, 
after which ECs were magnetically sorted. Isolated ECs were plated 
on fibronectin-coated T-25 flasks and cultured with DME containing 
endothelial growth supplement. Cells were trypsinized and charac-
terized by FACS analysis using anti–VE-cadherin, anti-VEGFR2, and 
anti-CD31 antibodies, which are known EC surface markers. We also 
determined tube formation in Matrigel as additional indices of EC 
characteristics. Isolated MLMVECs were more than 90% pure.
Human pulmonary artery endothelial cells (HPAECs) were 
cultured in a T-75 flask coated with gelatin and growth factor– 
supplemented EGM2 medium, as previously described. hMVECs were 
cultured in EBM-2 supplemented with 10% endotoxin-free fetal bovine 
serum (Omega Scientific). Adherent hMVECs were then cultured over-
night in 96-well plates at 1 × 106 cells/ml before being primed for 5 to 
6 hours with 1 μg/ml LPS or Pam3CSK4 in Opti-MEM (Life Technolo-
gies). Primed cells were transfected with 2 μg/ml LPS plus 0.25% v/v 
FuGENE HD (Promega).
MPO assay. Lungs were perfused with PBS to remove all blood, 
then weighed and frozen and stored at –80 °C for no more than 1 week 
before the MPO assay was performed. MPO activity was measured as 
previously described (4).
Immunoblotting. For immunoblotting, cells were lysed with RIPA 
buffer. Culture supernatants were precipitated with 7.2% trichloro-
acetic acid plus 0.15% sodium cholate. Protein concentrations were 
determined using Bradford (Bio-Rad). Proteins (20–50 μg) were 
boiled, separated on SDS-PAGE, and transferred onto PVDF mem-
branes (Bio-Rad). Membranes were blocked with 5% nonfat dry milk 
in PBS with 0.1% Tween 20 (PBST, Sigma-Aldrich) for 1 hour at room 
temperature and incubated overnight at 4 °C with primary antibodies. 
Densitometry analysis was performed using ImageJ software (NIH), 
and the data were normalized against β-actin.
Measurement of pulmonary vessel filtration coefficient. Mice were 
anesthetized with an i.p. injection of ketamine (100 mg/kg body 
weight) and xylazine (15 mg/kg body weight). Lungs were harvested 
and microvessel permeability was determined in isogravimetric lungs 
by determining microvascular filtration coefficient (Kf,c) (50). In brief, 
outflow pressure was elevated by 10 cm H2O for 20 minutes in isogravi-
metric perfused lungs. The lung wet weight gain during this time, which 
is the net fluid accumulation, was recorded. At the end of each experi-
ment, lung dry weight was determined. Kf,c (milliliters × min−1 × centime-
ters H2O × g dry weight−1) was calculated from the slope of the recorded 
weight change normalized to the pressure change and lung dry weight.
Evans blue–albumin pulmonary transvascular flux measurements. 
To measure vessel endothelial permeability, we performed Evans 
blue–albumin extravasation assay, which is a widely used and well- 
established in vivo method for a quantitative assessment of vascular 
permeability level (51). Physiological intact endothelium is perme-
able to water and ions and impermeable to proteins. Damaged endo-
thelial barrier function by inflammatory stimuli results in protein 
leakage. By injecting Evans blue dye, which binds albumin, we can 
assess the extent of protein leakage from the blood stream. Briefly, 
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control group. We collected blood from a peripheral vein into heparin 
tubes that were centrifuged (Universal 16R) for 5 minutes at 3,000 g 
(4°C). The plasma supernatant was removed from the spun samples 
and frozen at −80°C until the time of MP analysis.
Statistics. Data were analyzed by 2-tailed unpaired Student’s t 
test for comparisons of 2 groups or 1-way ANOVA of the repeated 
experiments followed by the Tukey’s post hoc pairwise multiple 
comparisons when appropriate with Prism 7 (GraphPad). P < 0.05 
was considered significant. For all bar graphs, the mean ± SEM is 
plotted. All in vitro experiments were repeated at least 3 times 
unless otherwise indicated.
Study approval. The Animal Care Committee and Institutional 
Biosafety Committee of the University of Illinois at Chicago approved 
all mouse protocols. The human study was approved by the Medical 
Ethics Committee of Guangdong General Hospital. Written informed 
consent was required from participants or their surrogates. Patients 
with surrogate consents were reconsented if they regained decision- 
making capacity during the hospitalization.
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For circulating plasma MP phenotyping experiments, 50 μl platelet- 
poor plasma (PPP) was stained with CD31-APC (endothelial marker) 
and CD41-FITC (platelet marker). Appropriate isotype and single stain 
controls were used. Samples were stained in the dark at room tempera-
ture for 30 minutes before acquisition with FlowSight. All samples were 
acquired on a FlowSight imaging cytometer, ×20 magnification, with 
low flow rate/high sensitivity using INSPIRE software (MilliporeSigma). 
The percentage of MPs positive for each lineage marker was measured.
The instrument and INSPIRE software were set up as follows: 
channels 01 (bright field), 09 (bright field 2) and 06 (scattering 
channel) plus fluorescence channels required. Magnification was 
×20, and the lasers 488, 642, and 745 were activated for fluorescence 
and side scatter. The flow rate was set to low speed/high sensitivi-
ty, and stream alignment was adjusted where necessary. To obtain a 
collection gate, a scatter plot of bright field object area (channel 01) 
was plotted against side scatter (channel 06) intensity; this allow us 
to set a gate for size discrimination. Each gated population was inter-
rogated via the image gallery to determine the upper and lower lim-
its of MP size and shape. MPs characteristically appear as small and 
can be discriminated from cells, which are much larger, or cellular 
debris, which is not uniformly spherical.
To determine the concentration of the sample, IDEAS software 
(MilliporeSigma) was used. Raw image files with the entire number 
of events were opened. A scatter plot showing fluorescence intensity 
plotted against scattering intensity was generated and an MP gate 
reapplied and inspected visually to exclude inappropriate events. 
The gate was adjusted where necessary. The objects/ml feature was 
added to the analysis area and applied to the MP gate. To analyze 
the number of MPs generated, all events falling in the MP gate were 
plotted on a scatter graph showing time versus objects per second.
Patient samples. A total of 14 ARD patients (4 males, 3 females) 
and CPE patients (5 males, 2 females) from the intensive care unit of 
the Guangdong General Hospital who were receiving mechanical ven-
tilation for ARD and CPE were enrolled. Data on demographic char-
acteristics and medical history are provided in Supplemental Table 1. 
Blood gas analysis of all patients showed PaO2/FiO2 less than or equal 
to 300 mmHg and APACHE II scores ranging from 14 to 32. A total 
of 10 stable outpatients (7 males, 3 females) were also enrolled as a 
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